US judge declines to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk
A US judge said Eli Lilly's advertisements had only a negligible effect on Novo Nordisk. Prescriptions for Novo Nordisk's products held steady.
BTC+0.39%
ETH+0.35%
SOL-0.51%
USDC+0.02%
XRP+0.78%
SUI+0.43%
GRAMTON-2.82%
DOGE+1.67%BTC+0.39%ETH+0.35%SOL-0.51%USDC+0.02%XRP+0.78%SUI+0.43%GRAMTON-2.82%DOGE+1.67%BTC+0.39%ETH+0.35%SOL-0.51%USDC+0.02%XRP+0.78%SUI+0.43%GRAMTON-2.82%DOGE+1.67%BTC+0.39%ETH+0.35%SOL-0.51%USDC+0.02%XRP+0.78%SUI+0.43%GRAMTON-2.82%DOGE+1.67%
